Evaluation of plasma thyrotrophin response to thyrotrophin releasing hormone in Graves' disease and in hyperactive thyroid adenoma before and after treatment.
D000236:Adenoma / Q000097:blood*; D000284:Administration, Oral; D001932:Brain Neoplasms / Q000097:blood; D006111:Graves Disease / Q000097:blood*; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood*; D007031:Hypothalamus; D007275:Injections, Intravenous; D010911:Pituitary Neoplasms / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood*; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin